Irving’s Caris Life Sciences receives $400M secured term loan


Caris Life Sciences plans to use the funding to repay outstanding debt, enhance its medicine platform and for general corporate purposes.

Previous Jacksonville commercial construction permits fell in 2022, but the cost increased substantially
Next Maui Health’s Mike Rembis to retire